Generex Biotechnology News

U.S. Markets plunged in Tuesday Midday trading as the Dow Jones Industrial Average drops 104 points to 8219.

Novo Nordisk wrote down $280 million for its investment in inhaled insulin in January of 2008, but this is dwarfed by Pfizer's write off in November of 2007 of $2.8 billion for its investment in Exubera, its entry into the inhaled insulin market.

"Stocks that Standout" picks for today are: CytRx Corporation , Generex Biotechnology Corporation , Micro Imaging Technology, Inc.

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the company has reviewed the positive data from its bioequivalent study with MetControl , its proprietary metformin chewing gum product study conducted in November 2008.

Jun 25, 2009 Generex Biotechnology Corporation closed at $0.56 on a volume of 3,951,944 shares.

Antigen Express Inc., a wholly owned subsidiary of Generex Biotechnology Corporation , has developed new vaccine technology that "could rapidly lead to safe, effective flu vaccines," according to a June 23, 2009 article in the Worcester, Massachusetts Telegram & Gazette.

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced the appointment of Stephen Fellows, CA to the position of Vice President of Finance as the Company plans for growth in sales for its current retail product portfolio and increased commercialization for its ...

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, provided an update on the status of the retail broker network for the Company's line of confectionary products available over-the-counter in Canada and the USA.

BOSTON, June 11 /PRNewswire/ -- GlobalEquityReport.com is pleased to offer its stock alerts service to the investing community.

Pennyperformers.com "Penny Stocks that Perform" picks are: Cell Therapeutics, Inc.

Generex Biotechnology , a biotech company focusing on drug delivery for metabolic diseases through the inner lining of the mouth, announced that it intends to sell up to 17.2 million shares of its common stock to accredited investors on Monday, June 15, 2009.

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received five new patents in Canada, Australia, New Zealand, Brazil and Lebanon.

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced the presentation of clinical data at The Endocrine Society's Annual Meeting being held in Washington, DC, June 10 - 13, 2009.

Our Stocks to Watch tomorrow include XTENT Inc. , Elysium Internet Inc. , Seamless Corp.

Del Mar, California - StockSource.us Reports on Stocks to Watch: Elray Resources, Inc.

WORCESTER,A Mass. Data from an early-stage clinical trial presented at the annual meeting of the American Society of Clinical Oncology indicate that an experimental vaccine for prostate cancer is safe, well-tolerated and produces the desired response, the vaccinea s manufacturer announced Monday.

Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has consummated a registered direct offering of 15,151,517 shares of its common stock to a select group of accredited investors at $0.33 per share.

BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for April 29, 2009.

Dr. Eric von Hofe featured on CBS/WBZ-TV Boston WORCESTER, MA, April 30, 2009 Eric von Hofe, PhD, president of Antigen Express, Inc.

Shares of niche makers of antiviral products and vaccines saw shares rocket in early trading Monday on news that the world could be facing a global pandemic of the swine flu virus.